No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
HIBB Hibbett Sports
- 86.150
- +0.050+0.06%
Close Apr 26 16:00 ET
- 85.550
- -0.600-0.70%
Post 17:41 ET
1.03BMarket Cap10.54P/E (TTM)
86.200High86.000Low556.82KVolume86.100Open86.100Pre Close47.93MTurnover5.60%Turnover Ratio10.54P/E (Static)11.95MShares86.70052wk High2.46P/B856.34MFloat Cap34.18252wk Low1.00Dividend TTM9.94MShs Float97.144Historical High1.16%Div YieldTTM0.23%Amplitude2.065Historical Low86.085Avg Price1Lot Size
Full Hours
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Hibbett Cut to Neutral From Outperform by Baird
Hibbett Cut to Neutral From Outperform by Baird
Hibbett Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/26/2024 2.33% Baird $80 → $87.5 Downgrades Outperform → Neutral 04/24/2024 2.33% B. Riley Securities $7
Baird Downgrades Hibbett to Neutral From Outperform, Price Target Is $87.50
Hibbett (HIBB) has an average rating of outperform and price targets ranging from $73 to $87.50, according to analysts polled by Capital IQ.
Maintaining Hold Rating Amid JD Sports' Proposed Acquisition of Hibbett Sports
Analysts Offer Insights on Consumer Cyclical Companies: Hibbett Sports (HIBB), NVR (NVR) and Packaging (PKG)
Key Takeaways From Hibbett Analyst Ratings
In the last three months, 8 analysts have published ratings on Hibbett (NASDAQ:HIBB), offering a diverse range of perspectives from bullish to bearish.The table below provides a concise overview of re
Comments
$Hibbett Sports(HIBB.US$ why it fell?
ColumnsToday's Morning Movers and Top Ratings: ADBE, RIVN, ULTA, DASH and More
Morning Movers
Gapping up
$Madrigal Pharmaceuticals(MDGL.US$ stock jumped 25% after the U.S. Food and Drug Administration approved its drug for a fatty liver disease known as non-alcoholic steatohepatitis.
$Rivian Automotive(RIVN.US$ stock rose 3.9% after Piper Sandler upgraded its stance on the EV manufacturer to overweight, citing growing excitement surrounding new product launches.
Gapping down
$Adobe(ADBE.US$ stock f...
Gapping up
$Madrigal Pharmaceuticals(MDGL.US$ stock jumped 25% after the U.S. Food and Drug Administration approved its drug for a fatty liver disease known as non-alcoholic steatohepatitis.
$Rivian Automotive(RIVN.US$ stock rose 3.9% after Piper Sandler upgraded its stance on the EV manufacturer to overweight, citing growing excitement surrounding new product launches.
Gapping down
$Adobe(ADBE.US$ stock f...
27
Hibbett's Q4 results were disappointing with misses on revenue, EPS, and same-store sales. The company's full-year EPS guidance was also below expectations. Despite the challenging quarter, the company's CEO highlighted a solid financial performance and a record full fiscal year sales of $1.73 billion.
2
Hibbett's upward trend, especially a strong ROCE, signals promising future and potential successful reinvestment opportunities. High investor expectations for future performance suggest a growth trend worth further investigation.
While Hibbett, Inc. is trading below the industry PE ratio, it comes with the risk of an expected negative growth. For potential investors, it's recommended to research further into the stock considering these risks.
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg